CHEARS News Room
Eli Lilly antibody trial paused over safety concern
14 October 2020
A government sponsored clinical trial by Eli Lilly was paused. Spokes person Molly McCully informed economictimes that company is more concerned towards safety of the patient and so the trial was paused. Same was also confirmed by the email sent to researchers from government officials. Eli Lilly is perusing the experimental treatment for COVID-19 that uses monoclonal antibodies.
It will be great, if you share your view on above write-up.
Your content has been submitted. Please refresh page to see comment